Skip to main content
Main navigation
News
Antimicrobial Resistance
COVID-19
Chronic Wasting Disease
Influenza
Resilient Drug Supply
All Topics A-Z
Coronavirus Vaccines Roadmap
Influenza Vaccines Roadmap
Roadmaps for Priority Pathogens
Vaccine Integrity Project
CIDRAP Leadership Forum
.
.
Topics & Projects
Antimicrobial Stewardship
Chronic Wasting Disease
Osterholm Update
Podcasts
Newsletters
About CIDRAP
CIDRAP in the News
Our Staff
Our Director
Osterholm in the Press
Shop Merchandise
Contact Us
About
Search
CLOSE
Search
Support
Menu
Search
Fulltext search
Dates
Dates
Min
Max
Submit
Type
Type
Articles
Blog post
News briefs
People
Podcasts
Topics
Submit
Infectious disease topic
Infectious disease topic
Acute Flaccid Myelitis
Adenovirus
Adult (non-flu) Vaccines
Anthrax
Anti-science
Antimicrobial Stewardship
Avian Influenza (Bird Flu)
Biosecurity Issues
Bioterrorism
Botulism
BSE
Burkholderia cepacia
Business Preparedness
Campylobacter
Candida auris
Chagas Disease
Chikungunya
Childhood Vaccines
Chlamydia
Cholera
Chronic Wasting Disease
Climate Change
Clostridium difficile
COVID-19
Cryptosporidium
Cyclospora
Dengue
Diagnostics
Diphtheria
Dracunculiasis
Dual-Use Research
E coli
Eastern Equine Encephalitis
Ebola
Elizabethkingia
Enterovirus
Enterovirus, Non-Polio
Fecal Transplant
Foodborne Disease
Fungal Infection
Glanders & Melioidosis
Gonorrhea
Guillain-Barre Syndrome
H1N1 2009 Pandemic Influenza
H3N2v Influenza
Healthcare-Associated Infections
Heartland Virus
Hemolytic Uremic Syndrome (HUS)
Hepatitis
HIV/AIDS
Human Papillomavirus (HPV)
Influenza Vaccines
Influenza Variants
Influenza, General
Jamestown Canyon Virus
Japanese Encephalitis
Klebsiella
Lassa
Legionella
Listeria
Lyme Disease
Malaria
Marburg
MCR-1
Measles
Meningitis
MERS-CoV
Misc Emerging Topics
Mpox
MRSA
Mumps
Nipah
Norovirus
Novel Coronavirus
Oropouche Virus
Orthopoxvirus
Pandemic Influenza
Pertussis
Plague
Pneumonia
Polio
Public Health
Rabies
Resilient Drug Supply
Respiratory Syncytial Virus (RSV)
Ricin
Rift Valley Fever
Rotavirus
Rubella
Salmonella
SARS
Sepsis
Sexually Transmitted Infections
Shigella
Smallpox
Swine Influenza
Tick-borne Disease
Tuberculosis
Tularemia
Typhoid
Vaccine Integrity Project
Valley Fever
Varicella
Viral Hemorrhagic Fever
West Nile
Yaws
Yellow Fever
Zika
Submit
1376 - 1400 of 5092 results
Sort options
Sort by Relevance
Sort by Date
European regulators to speed review of COVID-19 antiviral drug
… European regulators to speed review of
COVID
-19 antiviral drug … European regulators to speed review of
COVID
-19 antiviral drug Other authors Lisa Schnirring | News … Germany sees rising infections. Infectious disease topics
COVID
-19 Body The European Medicines Agency said today that …
Lisa Schnirring | News Editor | CIDRAP News
Global COVID-19 deaths may be 3 times higher than recorded
… Global
COVID
-19 deaths may be 3 times higher than recorded … Global
COVID
-19 deaths may be 3 times higher than recorded Other … Reporter | CIDRAP News Teaser image Teaser text The global
COVID
death toll is closer to 18.2 million through 2021, with …
Stephanie Soucheray | News Reporter | CIDRAP News
Air pollution may raise risk of positive COVID-19 test
… Air pollution may raise risk of positive
COVID
-19 test … Air pollution may raise risk of positive
COVID
-19 test Other authors Mary Van Beusekom | News Writer | … public health," one author says. Infectious disease topics
COVID
-19 Body An observational JAMA Network Open study today …
Mary Van Beusekom | News Writer | CIDRAP News
Long COVID tied to loss of smell that may be permanent
… Long
COVID
tied to loss of smell that may be permanent … Long
COVID
tied to loss of smell that may be permanent Other … News Teaser image Teaser text Of 219 unvaccinated long-
COVID
patients, 64% had a persistently impaired sense of …
Mary Van Beusekom | News Writer | CIDRAP News
Study: COVID-19 antibodies decay quickly after mild illness
… Study:
COVID
-19 antibodies decay quickly after mild illness … Study:
COVID
-19 antibodies decay quickly after mild illness Other … good news for vaccine prospects. Infectious disease topics
COVID
-19 Body Levels of antibodies against SARS-CoV-2, the …
Mary Van Beusekom | News Writer | CIDRAP News
Minority long-term care residents, staff bear heavy COVID burden
… Minority long-term care residents, staff bear heavy
COVID
burden … Minority long-term care residents, staff bear heavy
COVID
burden Other authors Mary Van Beusekom | News Writer | … with higher rates of minorities had almost 4 times the
COVID
-19 cases. Infectious disease topics
COVID
-19 Body …
Mary Van Beusekom | News Writer | CIDRAP News
Half of recovered COVID-19 patients report lingering fatigue
… Half of recovered
COVID
-19 patients report lingering fatigue … Half of recovered
COVID
-19 patients report lingering fatigue Other authors Mary … | CIDRAP News Teaser image Teaser text About 52% of 128
COVID
patients reported fatigue 10 weeks later, regardless of …
Mary Van Beusekom | News Writer | CIDRAP News
Some COVID-19 patients have brain complications, study suggests
… Some
COVID
-19 patients have brain complications, study suggests … Some
COVID
-19 patients have brain complications, study suggests … and dementia-like symptoms. Infectious disease topics
COVID
-19 Body Some
COVID
-19 patients, including those younger …
Mary Van Beusekom | News Writer | CIDRAP News
Study: Risk of severe COVID-19 imperils millions of uninsured
… Study: Risk of severe
COVID
-19 imperils millions of uninsured … Study: Risk of severe
COVID
-19 imperils millions of uninsured Other authors Mary … are uninsured or underinsured. Infectious disease topics
COVID
-19 Body Even before the pandemic, more than 18 million …
Mary Van Beusekom | News Writer | CIDRAP News
NSAIDs like ibuprofen not tied to severe COVID-19, death
… NSAIDs like ibuprofen not tied to severe
COVID
-19, death … NSAIDs like ibuprofen not tied to severe
COVID
-19, death Other authors Mary Van Beusekom | News Writer … the pandemic, the authors say. Infectious disease topics
COVID
-19 Body Contrary to early reports, the use of …
Mary Van Beusekom | News Writer | CIDRAP News
Global COVID-19 activity shows continued variation
… Global
COVID
-19 activity shows continued variation … Global
COVID
-19 activity shows continued variation Other authors … the week before, the WHO says. Infectious disease topics
COVID
-19 Body In its weekly snapshot of global pandemic …
Lisa Schnirring | News Editor | CIDRAP News
Global COVID-19 cases climb for 6th straight week
… Global
COVID
-19 cases climb for 6th straight week … Global
COVID
-19 cases climb for 6th straight week Other authors Lisa … tied to the AstraZeneca vaccine. Infectious disease topics
COVID
-19 Body The world's number of new
COVID
-19 cases rose …
Lisa Schnirring | News Editor | CIDRAP News
COVID-19 Scan for May 04, 2021
…
COVID
-19 Scan for May 04, 2021 …
COVID
-19 Scan for May 04, 2021 Bullet points Declining
COVID
in-hospital deaths Mental health in older adults Body …
WHO advisors say COVID-19 pandemic far from over
… WHO advisors say
COVID
-19 pandemic far from over … WHO advisors say
COVID
-19 pandemic far from over Other authors Lisa Schnirring … and political division. Infectious disease topics
COVID
-19 Body After reviewing the latest
COVID
-19 …
Lisa Schnirring | News Editor | CIDRAP News
FDA panel green-lights Pfizer COVID vaccine for young kids
… FDA panel green-lights Pfizer
COVID
vaccine for young kids … FDA panel green-lights Pfizer
COVID
vaccine for young kids Other authors Lisa Schnirring | … to 11 on an emergency use basis. Infectious disease topics
COVID
-19 Body The US Food and Drug Administration (FDA) …
Lisa Schnirring | News Editor | CIDRAP News
FDA authorizes COVID breath test for emergency use
… FDA authorizes
COVID
breath test for emergency use … FDA authorizes
COVID
breath test for emergency use Other authors Lisa … resume operations in Shanghai. Infectious disease topics
COVID
-19 Body The US Food and Drug Administration (FDA) …
Lisa Schnirring | News Editor | CIDRAP News
WHO backs Paxlovid for high-risk COVID patients
… WHO backs Paxlovid for high-risk
COVID
patients … WHO backs Paxlovid for high-risk
COVID
patients Other authors Lisa Schnirring | News Editor | … infections in high-risk groups. Infectious disease topics
COVID
-19 Body The World Health Organization (WHO) today …
Lisa Schnirring | News Editor | CIDRAP News
No anaphylaxis after second dose of mRNA COVID vaccine, study finds
… No anaphylaxis after second dose of mRNA
COVID
vaccine, study finds … No anaphylaxis after second dose of mRNA
COVID
vaccine, study finds Other authors Mary Van Beusekom | … any issues after the second. Infectious disease topics
COVID
-19 Body People who had a severe allergic reaction to …
Mary Van Beusekom | News Writer | CIDRAP News
Study: 20% of COVID-19 survivors report symptoms 2 years later
… Study: 20% of
COVID
-19 survivors report symptoms 2 years later … Study: 20% of
COVID
-19 survivors report symptoms 2 years later Other … new-onset or worsening symptoms. Infectious disease topics
COVID
-19 Body Two years after hospital release, nearly 20% of …
Mary Van Beusekom | News Writer | CIDRAP News
Global COVID-19 cases plateau, but deaths rise
… Global
COVID
-19 cases plateau, but deaths rise … Global
COVID
-19 cases plateau, but deaths rise Other authors Lisa … the Novavax vaccine for adults. Infectious disease topics
COVID
-19 Body Global
COVID
-19 activity stayed high and …
Lisa Schnirring | News Editor | CIDRAP News
Study: Pfizer COVID vaccine efficacy wanes 27 days after dose 2 in teens
… Study: Pfizer
COVID
vaccine efficacy wanes 27 days after dose 2 in teens … Study: Pfizer
COVID
vaccine efficacy wanes 27 days after dose 2 in teens … teens, if research supports it. Infectious disease topics
COVID
-19 Body A new study finds waning Pfizer/BioNTech …
Mary Van Beusekom | News Writer | CIDRAP News
Study: Few veterans used COVID-19 antivirals, antibodies
… Study: Few veterans used
COVID
-19 antivirals, antibodies … Study: Few veterans used
COVID
-19 antivirals, antibodies Other authors Stephanie … antibodies and antivirals Infectious disease topics
COVID
-19 Body In January and February of 2022—when the …
Stephanie Soucheray | News Reporter | CIDRAP News
COVID-19 cases climb in the US and Europe
…
COVID
-19 cases climb in the US and Europe …
COVID
-19 cases climb in the US and Europe Other authors Lisa … herd immunity response concept. Infectious disease topics
COVID
-19 Body A third
COVID
-19 spike in the United States …
Lisa Schnirring | News Editor | CIDRAP News
Studies show good COVID booster effect, waning 2nd-dose protection
… Studies show good
COVID
booster effect, waning 2nd-dose protection … Studies show good
COVID
booster effect, waning 2nd-dose protection Other … text Israelis who got a booster dose had 11.3 times fewer
COVID
-19 infections. Infectious disease topics
COVID
-19 Body …
Mary Van Beusekom | News Writer | CIDRAP News
Eagerly awaited COVID lifesavers molnupiravir, Paxlovid now wait for patients
… Eagerly awaited
COVID
lifesavers molnupiravir, Paxlovid now wait for patients … Eagerly awaited
COVID
lifesavers molnupiravir, Paxlovid now wait for patients … want them. Infectious disease topics Resilient Drug Supply
COVID
-19 Body Editor's note: This story was updated on Feb …
Mary Van Beusekom | News Writer | CIDRAP News
Pagination
« First
First page
‹‹
Previous page
…
52
53
54
55
56
57
58
59
60
…
››
Next page
Last »
Last page
Our underwriters
Unrestricted financial support provided by
Principal Underwriter
Leading Underwriter
Major Underwriter
Supporting Underwriter
Supporting Underwriter
News
Topics & Projects
Antimicrobial Resistance
COVID-19
Chronic Wasting Disease
Influenza
Resilient Drug Supply
All Topics A-Z
Coronavirus Vaccines Roadmap
Influenza Vaccines Roadmap
Roadmaps for Priority Pathogens
Vaccine Integrity Project
CIDRAP Leadership Forum
.
.
Podcasts
Antimicrobial Stewardship
Chronic Wasting Disease
Osterholm Update
Newsletters
About
About CIDRAP
CIDRAP in the News
Our Staff
Our Director
Osterholm in the Press
Shop Merchandise
Contact Us
Donate